These results further proved that DDX17 plays a role in lipid metabolism, activation of M1 macrophages and subsequent inflammatory responses through the regulation of Cyp2c29 during the progression of NASH. Here, DDX17 is linked to metabolic dysfunction-associated steatohepatitis.